Angewandte
Chemie
kinetic lability of the peptide–DNA complex,which may
partially dissociate under the conditions of the assay.[12]
Ensuring the presence of enough dsDNA (> 20 nm),we
obtained clear complexation results upon titration of the
target DNA with increasing amounts of equimolecular
mixtures of 3a and 7a,or with fixed concentrations of one
of the partners and increasing proportions of the other
(Figure 3c). Titration assays in the presence of an excess of
the tripyrrole 7a,therefore ensuring that most of the dsDNA
probe is saturated,allowed calculation of an approximate Kd
value of 3a for a DNA·7a complex of 63 Æ 7 nm (see the
Supporting Information). Assuming that the BR monomeric
peptide binds DNA with affinities in the range of 1–5 mm,[12]
we can infer that the presence of 7a induces a very important
binding improvement.
In conclusion,attachment of complementary noncovalent
heterodimerizing units at a side chain of a distamycin-related
tripyrrole and at the C terminus of a bZIP BR peptide
provides for sequence-specific DNA recognition of relatively
long DNA sites (8–9 bp). This strategy,which must involve a
major- and minor-groove interaction,allows the DNA binding
of very short peptides (23 amino acids) in a highly sequence-
specific manner and represents a first step towards the
development of small,highly selective and ligand-responsive
DNA-binding peptides. Current studies are focused on
further characterizing the binding mode,refining the system
to obtain more stable complexes,and extending the recog-
nition strategy to other transcription factor fragments.
Figure 3. EMSA results showing the binding of peptide 3a to dsDNA
molecules. Experiments for (a) and (b) were analyzed by fluorescent
dye staining and those of c) were analyzed by autoradiography.
a) [dsDNA]ꢀ30 nm. Lanes 1–5: 7a in the presence of a mixture of
3a+CREhs/A, [3a]=200 nm, [7a]=0, 50, 100, 200, 400 nm; lanes 6–
10: 7a in the presence of a mixture of 3a+CREhsm/A, [3a]=200 nm,
[7a]=400, 200, 100, 50, 0 nm; lanes 11,12: 7a in the presence of a
mixture of 3a+CREhs, [3a]=5 mm, [7a]=0.5, 1 mm; lane 13:
CRE+3b+3c, [3b]=[3c]=500 nm; lane 14: 3a+CREhs/A+7b,
[3a]=2 mm, [7b]=500 nm; lane 15: 3d+CREhs/A+7a, [3d]=2 mm,
[7a]=500 nm. b) [dsDNA]ꢀ30 nm. Lanes 1–5: 7a in the presence of a
mixture of 3a+CREhs/A, [3a]=200 nm, [7a]=0, 50, 100, 200, 400 nm;
lanes 6–10: 7a in the presence of a mixture of 3a+CREhsg/A,
[3a]=200 nm, [7a]=0, 50, 100, 200, 400 nm; lanes 11–15: 7a in the
presence of a mixture of 3a+CREhscg/A, [3a]=200 nm, [7a]=0, 50,
100, 200, 400 nm; lanes 16–20: 7a in the presence of a mixture of
3a+CREhsg/Am, [3a]=200 nm, [7a]=0, 50, 100, 200, 400 nm. c) Auto-
radiograms with 32P-labeled CREhs/A (ꢀ45 pm of 32P-labeled +
100 nm unlabeled). Lanes 1–8: equimolecular mixture of 3a and 7a,
[3a]=0, 50, 80, 100, 150, 200, 250, 300 nm; lanes 9–15: 3a in the
presence of a mixture of 7a+CREhs/A, [7a]=200 nm, [3a]=50, 80,
100, 150, 200, 250, 300 nm; lanes 16–22: 7a in the presence of a
mixture of CREhs/A+3a, [3a]=200 nm, [7a]=50, 80, 100, 150, 200,
250, 300 nm. Sequences of one strand of the ds-oligonucleotides used:
CREhs: 5’-d(CGAACGTCATCGAAGGTCCT)-3’; CRE: 5’-d(TGGAGAT-
GACGTCATCTCGT)-3’; CREhsg/A: 5’-d(CGAACGTCATGAAAATCCTC)-3’;
CREhscg/A: 5’-d(CGAACGTCATCGAAAATCCT)-3’; CREhsg/Am: 5’-
d(CGAACGTCATGAAAGTCCTC)-3’. The BR subsite (CREhs) is shown
underlined, and the tripyrrole subsite is shown in italics.
Experimental Section
Circular dichroism measurements were made in a 2-mm cell at 48C.
Samples contained 10 mm phosphate-buffered saline solution
(pH 7.5),100 m m NaCl,5 mm peptide,and 5 mm ds-oligonucleotide
when present. The peptide–DNA mixtures were incubated for 5 min
before registering. For gel mobility shift assays,binding reactions
were performed over 30 min in a binding mixture (20 or 40 mL)
containing 18 mm tris(hydroxymethyl)aminomethane (Tris; pH 7.5),
À1
90 mm KCl,1.8 m m MgCl2,1.8 m m EDTA,9% glycerol,0.11 mgmL
bovine serum albumin (BSA) and 2.2% NP-40 (nonidet-P40).
Products were resolved by PAGE by using a 10% nondenaturing
polyacrylamide gel and 0.5XTBE buffer solution (44.5 mm Tris,
44.5 mm boric acid,1 m m EDTA,pH 8) and analyzed by auto-
radiography (when radioactivity was used) or by staining with
SyBrGold (Molecular Probes: 5 mL in 50 mL of 1XTBE) for 10 min
and visualized with fluorescence.
Received: August 1,2006
Revised: October 13,2006
Published online: November 17,2006
Keywords: distamycin · DNA recognition ·
noncovalent interactions · peptides · proteins
cleotide CREhsg/A completely abolishes the complexation
(CREhsg/Am,Figure 3b,lanes 16–20). These data confirm the
high specificity of the system and are consistent with the
proposed major–minor groove interaction model.
.
Standard EMSA experiments by using 32P-end-labeled
dsDNA molecules revealed that to detect the bands of the
complex it is necessary to use larger amounts of the dsDNA
than commonly used in this type of assay. Well-known
precedents for related systems suggest that such a require-
ment could probably be a consequence of a relatively high
[1] R. J. White, Gene Transcription, Mechanism and Control,Black-
well Science,Oxford, 2001.
[2] a) C. O. Pabo,R. T. Sauer, Annu. Rev. Biochem. 1992, 61,1053 –
1095; b) D. S. Latchman, Transcriptional Factors: Structural
Families and Principles of DNA Recognition,Academic Press,
San Diego, 1998; c) C. W. Garvie,C. Wolberger, Mol. Cell 2001,
8,936 – 946; d) J. T. Kadonaga, Cell 2004, 116,247 – 257; e) N. M.
Angew. Chem. Int. Ed. 2006, 45, 8210 –8214
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
8213